Leidos (NYSE:LDOS) Given New $210.00 Price Target at Barclays

Leidos (NYSE:LDOS) had its price target increased by Barclays from $165.00 to $210.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an overweight rating on the aerospace company’s stock.

Other research analysts have also recently issued research reports about the company. Royal Bank of Canada lifted their price objective on Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a research note on Wednesday, October 30th. Robert W. Baird upped their price target on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. JPMorgan Chase & Co. raised their price objective on shares of Leidos from $175.00 to $185.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Citigroup upped their target price on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Finally, Truist Financial raised their price target on shares of Leidos from $175.00 to $205.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $191.23.

Leidos Stock Up 2.2 %

NYSE:LDOS opened at $194.20 on Monday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The firm’s 50-day moving average price is $165.11 and its 200-day moving average price is $152.75. The company has a market capitalization of $25.91 billion, a PE ratio of 22.12, a P/E/G ratio of 1.48 and a beta of 0.68. Leidos has a 1-year low of $102.21 and a 1-year high of $198.99.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The business had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.06 billion. During the same quarter in the prior year, the company earned $2.03 earnings per share. The business’s revenue was up 6.9% compared to the same quarter last year. On average, equities analysts predict that Leidos will post 10.07 EPS for the current fiscal year.

Leidos Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be issued a $0.40 dividend. This is an increase from Leidos’s previous quarterly dividend of $0.38. The ex-dividend date is Friday, December 13th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.82%. Leidos’s dividend payout ratio (DPR) is presently 17.31%.

Insider Buying and Selling at Leidos

In other news, Director Gary Stephen May sold 1,000 shares of the business’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total transaction of $144,020.00. Following the completion of the sale, the director now owns 11,264 shares of the company’s stock, valued at $1,622,241.28. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Gary Stephen May sold 1,000 shares of Leidos stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the transaction, the director now directly owns 11,264 shares of the company’s stock, valued at $1,622,241.28. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of LDOS. Allspring Global Investments Holdings LLC raised its holdings in Leidos by 51.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after acquiring an additional 283,558 shares during the period. Twin Tree Management LP purchased a new position in Leidos in the 1st quarter worth approximately $2,512,000. Point72 Asia Singapore Pte. Ltd. boosted its stake in Leidos by 188.2% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,274 shares of the aerospace company’s stock worth $1,207,000 after purchasing an additional 5,403 shares during the period. Advisors Asset Management Inc. grew its holdings in Leidos by 97.2% during the 1st quarter. Advisors Asset Management Inc. now owns 12,904 shares of the aerospace company’s stock valued at $1,692,000 after buying an additional 6,360 shares in the last quarter. Finally, AQR Capital Management LLC raised its position in shares of Leidos by 76.9% during the second quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock valued at $101,942,000 after buying an additional 303,775 shares during the last quarter. Institutional investors own 76.12% of the company’s stock.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.